Programs | Implementing Recommendations for HIV Management in the Primary Care Setting

View the HIV webcast here

Despite the significant advances in the treatment of human immunodeficiency virus (HIV) infection, surveillance data have shown an increasing trend in new cases, with many cases diagnosed at an advanced stage.  The Centers for Disease Control and Prevention (CDC) has issued recommendations for expanding screening and promoting early diagnosis of HIV inection.  Primary care providers, who are on the front lines of patient care, are in the best position to improve screening practices and early HIV diagnosis.  Both prevalence-based testing and risk-based testing require a thorough knowledge of epidemiologic trends and statistical data, especially regarding subpopulations at increased risk for HIV.

In this program, we will discuss a number of issues that are important to primary care clinicians  who manage patients at risk for, or who have recently become infected with HIV.  The program will review epidemiologic and statistical prevalence data on HIV in the United States, the rationale for current efforts to expand screening, and methods to improve the primary care provider's ability to diagnose this disease early in its course.  We will discuss the available types of HIV tests, some of the barriers to optimizing HIV testing, and strategies to overcome these barriers.  In addition, we will review the latest evidence-based recommendations for  managing HIV in treatment-naive patients.  Finally, we will discuss how primary care providers can confidently integrate HIV management into their clinical practice.

• Identify high-risk behaviors that impact the screening and early diagnosis of HIV in military veterans of the United States
• Describe current guideline recommendations for diagnosis and initial treatment of HIV
• Identify initial HIV treatment with regard to clinical practice of the military health care provider, consistent with current Veterans Affairs drug use guidelines  

Panel Members:

Accreditation Information:

Global Education Group (Global) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Global Education Group designates this continuing education activity for 1 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Numbers 053-9999-10-083-L01-P and 0530-9999-10-083-H01-P.  This is a knowledge-based activity. 

Nurses

This educational activity for 1.0 contact hour is provided by Global Education Group.

Global Education Group is an approved provider of continuing nursing education by the Colorado Nurses Association, an accredited approver by the AmericanNursesCredentialingCenter’s Commission on Accreditation.

This activity is jointly sponsored by  SCEPTER^TM and Quintiles Medical Education.

This activity is co-provided by Global Education Group and SCEPTER^TM.

This activity is supported by an educational grant from Bristol-Myers Squibb.

The opinions expressed in this program are those of the speaker and do not necessarily reflect the opinions or recommendations of the speaker's affiliated institutions, the publisher, SCEPTER^TM and Quintiles Medical Education, Global Education Group and  SCEPTER^TM (the accreditor), Bristol-Myers Squibb (the commercial supporter), or CRM Healthcare.  Any medications or other diagnostic or treatment procedures discussed by the program speakers should not be utilized by clinicians without evaluation of their patients' conditions and possible contraindications or risks or without a review of any applicable manufacturer's product information and comparison with the recommendations of other authorities.